In this case, some effector molecules as adverse prognosis markers will also be the potential therapeutic target for cancer and even can be the reliable strategy to overcome drug resistance.24, 25 As shown above, PLOD2 was confirmed to be a potential therapeutic target for metastasis. Here, PLOD2 is linked to cancer.